Pharma Journalist
  • facebook
  • twitter
  • google_plus
  • Email
Pharma Journalist

MSD Completes $5.8 Billion Terns Pharmaceuticals Acquisition

Madrigal Licenses Gene Therapy Candidate for MASH Treatment

Citius Oncology Secures $36.5M to Boost LYMPHIR Launch

PhaseBio Announces Completion of Dosing in First Cohort of Phase 1 Clinical Trial of PB2452

Read more

MyoKardia Begins Dosing in Phase 2 MAVERICK-HCM Clinical Trial of Mavacamten

Read more

Agilent Technologies Signs Agreement to Acquire Lasergen

Read more

Ferring Acquires Innovative Biotechnology Company and Microbiome Pioneer Rebiotix

Read more

Ubiquigent and FORMA Enter an Exclusive R&D Collaboration to Develop Novel DUB Inhibitors

Read more

Cardiva Medical Announces FDA Approval of VASCADE Vascular Closure System for Use in Femoral Vein Closure

Read more

Accelovance and Linical merge organizations to form a best-in-class CRO with increased global reach

Read more

Boehringer Ingelheim and OSE Announce Global Immuno-Oncology Partnership

Read more

Aradigm Announces the EMA Has Completed Its Validation of the MAA Submission

Read more

The National Institutes of Health announce Biobanking Medical Project

Read more

Posts pagination

Previous Page 1 of 923 … Page 752 of 923 … Page 923 of 923 Next
  • About
  • Advertise
  • Subscribe
  • Contact
View Desktop Version